Transcranial direct current stimulation for Autism Spectrum Disorder

Phase-Based Progress Estimates
1
Effectiveness
1
Safety
American University, Washington, United States
Autism Spectrum Disorder+2 More
Transcranial direct current stimulation - Device
Eligibility
18 - 65
All Sexes
What conditions do you have?
Select

Study Summary

The goal of this study is to determine the impact of neuromodulation to the cerebellum on social and executive functions in neurotypical young adults and young adults with autism.

Eligible Conditions

  • Autism Spectrum Disorder
  • Autism, Early Infantile

Treatment Effectiveness

Effectiveness Progress

1 of 3

Study Objectives

4 Primary · 0 Secondary · Reporting Duration: Within 30min post-tDCS

Within 30min post-tDCS
Cyberball social ball-playing task
Flexible Item Selection Test
Reading the Mind in the Eyes Test Adult Version
Within 45min post-tDCS
Functional MRI data

Trial Safety

Safety Progress

1 of 3

Trial Design

2 Treatment Groups

Right cerebellum
1 of 2
Posterior vermis
1 of 2
Experimental Treatment

80 Total Participants · 2 Treatment Groups

Primary Treatment: Transcranial direct current stimulation · No Placebo Group · N/A

Right cerebellum
Device
Experimental Group · 1 Intervention: Transcranial direct current stimulation · Intervention Types: Device
Posterior vermis
Device
Experimental Group · 1 Intervention: Transcranial direct current stimulation · Intervention Types: Device
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Transcranial direct current stimulation
2019
Completed Phase 3
~690

Trial Logistics

Trial Timeline

Approximate Timeline
Screening: ~3 weeks
Treatment: Varies
Reporting: within 30min post-tdcs
Closest Location: American University · Washington, United States
Photo of washington 1Photo of washington 2Photo of washington 3
2007First Recorded Clinical Trial
1 TrialsResearching Autism Spectrum Disorder
9 CompletedClinical Trials

Who is running the clinical trial?

National Institutes of Health (NIH)NIH
2,390 Previous Clinical Trials
24,521,477 Total Patients Enrolled
19 Trials studying Autism Spectrum Disorder
2,341 Patients Enrolled for Autism Spectrum Disorder
National Institute of Mental Health (NIMH)NIH
2,490 Previous Clinical Trials
1,765,991 Total Patients Enrolled
70 Trials studying Autism Spectrum Disorder
37,618 Patients Enrolled for Autism Spectrum Disorder
American UniversityLead Sponsor
18 Previous Clinical Trials
4,525 Total Patients Enrolled
Catherine Stoodley, D.Phil.Principal InvestigatorAmerican University

Eligibility Criteria

Age 18 - 65 · All Participants · 10 Total Inclusion Criteria

Mark “yes” if the following statements are true for you:
You are aged 18-35.
You are a native English speaker.
You are right-handed.
You are not pregnant.\n
Pass MRI and neuromodulation safety screening.

About The Reviewer

Michael Gill preview

Michael Gill - B. Sc.

First Published: October 9th, 2021

Last Reviewed: August 12th, 2022

Michael Gill holds a Bachelors of Science in Integrated Science and Mathematics from McMaster University. During his degree he devoted considerable time modeling the pharmacodynamics of promising drug candidates. Since then, he has leveraged this knowledge of the investigational new drug ecosystem to help his father navigate clinical trials for multiple myeloma, an experience which prompted him to co-found Power Life Sciences: a company that helps patients access randomized controlled trials.